Amber Siegfried

Bachelor of Medicine and Bachelor of Science,  The Johns Hopkins Hospital 

Location: India

Consulting Services

Admin and Customer Support IT-Web-Mobile Technology

Areas Of Interest

Proto Oncogene Proteins, Cellular Admission Test, Hospital Fractures, Dislocation Birt-Hogg-Dube Syndrome Dictionaries, Chemical as Topic Bronchitis BIV Transfer RNA Teratologies Chemical Accidents Brain Cancers Cortex, Prepyriform Milk Secretions Sodium Channel Preimplantation Diagnosis SOXD Transcription Factors Uterine Aspirators Receptors, Ionotropic Glutamate Broca's Area SAP 90 Protein Mainframe Computers Deficiency, Ascorbic Acid Telophase Mono ADPribose Transferases Pyurias Provitamins alpha Subunit Transducin Balloon Catheterization, Fogarty Cystathionine gamma-Lyase Exodeoxyribonuclease V Institutional Review Board foamy viruses, Human Jervell-Lange Nielsen Syndrome Occipital Lobes Mastoid Fontanels Menogaril, (5 alpha,11 beta)-Isomer Hypothalamic Nucleus, Anterior Micronized Procetofen, Antara Remodelings, Pulmonary Arterial Piren Basan

Professional Narrative

Dr. Amber Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2005
Director Medicine, Harvard Med 1988

Education

Doctor of medicine, Baylor College 2003
Bachelor of science in nursing, Perelman School of Medicine 2007

Referees


Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :